Results 191 to 200 of about 6,496,822 (268)
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts+8 more
wiley +1 more source
Overlapping attempts to falsify and Darwinize the Gaia hypothesis. [PDF]
Boyle R.
europepmc +1 more source
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian+10 more
wiley +1 more source
Chaos control and sensitivity analysis of climate change under green gases and carbon omission utilizing caputo fractional operator. [PDF]
Ahmad A+5 more
europepmc +1 more source
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga+8 more
wiley +1 more source
Mössbauer, optical, magnetic, electrochemical and antibacterial studies of the Ag/Sr<sub>0.85</sub>Ag<sub>0.15</sub>FeO<sub>3-δ</sub> composite. [PDF]
Abdel-Khalek EK+3 more
europepmc +1 more source